![](/img/cover-not-exists.png)
Targeted therapy: Apatinib — new third-line option for refractory gastric or GEJ cancer
Aoyama, Toru, Yoshikawa, TakakiLanguage:
english
Journal:
Nature Reviews Clinical Oncology
DOI:
10.1038/nrclinonc.2016.53
Date:
April, 2016
File:
PDF, 146 KB
english, 2016